Infectious Diseases Clinical Trial
Official title:
Comparative Study of 70% Isopropyl Alcohol Against 2% Chlorhexidine- 70% Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination
Verified date | August 2012 |
Source | Universidad de Guanajuato |
Contact | n/a |
Is FDA regulated | No |
Health authority | Mexico: Secretaria de Salud |
Study type | Interventional |
The purpose of this study is to determinate if 70% isopropyl alcohol is not inferior preventing contamination of peripheral hemocultures, compared with 2% chlorhexidine in 70% isopropyl alcohol.
Status | Completed |
Enrollment | 1102 |
Est. completion date | August 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Patients with suspected blood stream infection. - Patients allocated in admission, hospitalization and intensive care units. Exclusion Criteria: - Patients with a single peripheral hemoculture. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Mexico | University of Guanajuato School of Medicine | Leon | Guanajuato |
Lead Sponsor | Collaborator |
---|---|
Universidad de Guanajuato |
Mexico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Determine if 70% isopropyl alcohol is not inferior preventing contamination of peripheral hemoculture, compared with 2% chlorhexidine in 70% isopropyl alcohol. | It will determine the growth of contaminating germs in hemocultures taken with each antiseptic tested. | 120 hours | Yes |
Secondary | Determine the rate of contamination of each antiseptic used. | It will determine the rate of contamination at the date of primary completion and the date of study completion. We will consider contaminants the development of Staphylococcus coagulase negative and gram positive bacilli. | 1 year | Yes |
Secondary | Description of the most frequent bacterial contaminants. | It will determine the rate of contamination at the date of primary completion and the date of study completion. We will consider contaminants the development of Staphylococcus coagulase negative and gram positive bacilli. | 1 year | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02763345 -
The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi
|
N/A | |
Completed |
NCT00550706 -
Drug Utilization Prevalence in a Pediatric Care Medical Center
|
N/A | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Completed |
NCT00761462 -
BAY 0 9867 Cipro Pediatric Use Study (QUIP)
|
Phase 3 | |
Completed |
NCT05088421 -
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00828971 -
A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
|
Phase 3 | |
Completed |
NCT05468723 -
Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
|
||
Recruiting |
NCT02162966 -
Safety and Efficacy Study of High Dose Colistin
|
Phase 4 | |
Recruiting |
NCT00001281 -
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
|
||
Active, not recruiting |
NCT02654210 -
LoewenKIDS - Infections and the Development of the Immune System
|
||
Completed |
NCT02226263 -
Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
|
Phase 2 | |
Terminated |
NCT00211471 -
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
|
Phase 2 | |
Active, not recruiting |
NCT04342702 -
A Study on the Prospective Cohort Library of COVID-19 in Southeran
|
||
Completed |
NCT02134548 -
Sensitivity Study of Diagnostic for Detection of Chagas Infection
|
N/A | |
Active, not recruiting |
NCT01611025 -
Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time
|
N/A | |
Completed |
NCT00638677 -
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
|
Phase 4 | |
Completed |
NCT02434848 -
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
|
Phase 2/Phase 3 | |
Completed |
NCT02544139 -
Specificity Study of Diagnostic for Chagas Disease
|
N/A | |
Completed |
NCT00276198 -
Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants
|
Phase 3 | |
Completed |
NCT02111564 -
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
|
Phase 3 |